BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.76% |
| 2 | Healthcare | 6.75% |
| 3 | Financials | 5.74% |
| 4 | Consumer Discretionary | 5.28% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
CryoPort
CYRX
$772M
| $168K | ﹤0.01% |
9,825
+6,108
| +164% | +$107K |
|
2802
Bank of Montreal
BMO
$130B
| $167K | ﹤0.01% |
3,326
| – | – |
|
|
EBSB
2803
DELISTED
Meridian Bancorp, Inc.
EBSB
| $167K | ﹤0.01% |
14,855
+3,482
| +31% | +$57.7K |
|
2804
CNX Resources
CNX
$5.28B
| $167K | ﹤0.01% |
31,322
-151,256
| -83% | -$1.01M |
|
|
PRMW
2805
DELISTED
Primo Water Corporation
PRMW
| $166K | ﹤0.01% |
11,889
+6,765
| +132% | +$96.5K |
|
|
TWO
2806
Two Harbors Investment
TWO
$1.27B
| $166K | ﹤0.01% |
10,919
-1,821
| -14% | -$93K |
|
|
BFS
2807
Saul Centers
BFS
$860M
| $166K | ﹤0.01% |
5,079
+1,621
| +47% | +$73.2K |
|
|
CMO
2808
DELISTED
Capstead Mortgage Corp.
CMO
| $165K | ﹤0.01% |
39,372
-2,688
| -6% | -$19.2K |
|
2809
Amplify Cybersecurity ETF
HACK
$2.98B
| $165K | ﹤0.01% |
+4,622
| New | +$187K |
|
2810
Q32 Bio
QTTB
$451M
| $164K | ﹤0.01% |
587
+425
| +262% | +$130K |
|
2811
CALL
Eversource Energy
ES
$27.2B
| $164K | ﹤0.01% |
+21
| New | +$1.84K |
|
|
2812
PUT
Eversource Energy
ES
$27.2B
| $164K | ﹤0.01% |
+21
| New | +$1.84K |
|
|
LBAI
2813
DELISTED
Lakeland Bancorp Inc
LBAI
| $164K | ﹤0.01% |
15,128
+9,457
| +167% | +$140K |
|
|
TVRD
2814
Tvardi Therapeutics
TVRD
$23.7M
| $164K | ﹤0.01% |
344
+213
| +163% | +$116K |
|
2815
Collegium Pharmaceutical
COLL
$916M
| $163K | ﹤0.01% |
9,995
+6,189
| +163% | +$128K |
|
2816
iShares MSCI Indonesia ETF
EIDO
$489M
| $163K | ﹤0.01% |
11,063
+4,092
| +59% | +$90.3K |
|
2817
LeMaitre Vascular
LMAT
$1.88B
| $163K | ﹤0.01% |
6,538
+2,872
| +78% | +$88.7K |
|
2818
WillScot Mobile Mini Holdings
WSC
$4.31B
| $163K | ﹤0.01% |
16,054
+6,821
| +74% | +$111K |
|
|
TCDA
2819
DELISTED
Tricida, Inc. Common Stock
TCDA
| $162K | ﹤0.01% |
7,374
+4,202
| +132% | +$135K |
|
2820
Sally Beauty Holdings
SBH
$1.54B
| $161K | ﹤0.01% |
19,898
-116,571
| -85% | -$1.55M |
|
2821
AMC Global Media
AMCX
$510M
| $160K | ﹤0.01% |
6,568
-983
| -13% | -$33.3K |
|
|
DVAX
2822
DELISTED
Dynavax Technologies
DVAX
| $159K | ﹤0.01% |
45,024
+31,955
| +245% | +$148K |
|
|
DENN
2823
DELISTED
Denny's
DENN
| $159K | ﹤0.01% |
20,647
+6,703
| +48% | +$114K |
|
2824
Quince Therapeutics
QNCX
$34.6M
| $158K | ﹤0.01% |
17
+9
| +113% | +$88.8K |
|
|
HEES
2825
DELISTED
H&E Equipment Services
HEES
| $158K | ﹤0.01% |
10,787
+3,756
| +53% | +$90.9K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.